Please assess the completion status of the following clinical trial:

Trial Title: Effects of Exercise in Combination With Epoetin Alfa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Those who were not at high risk for impending pathologic fracture or cord compression, as determined by magnetic resonance imaging and other radiology reports and physician assessments,and enrolled in Total Therapy treatment protocols were invited to participate in the study.~Exclusion Criteria:~Patients were excluded if they showed any of the following attributes/conditions:~* Inability to understand the intent of the study~* Current diagnosis with a major psychiatric illness~* Presence of microcytic or macrocytic anemia~* Uncontrolled hypertension~* Red cell transfusions within 2 weeks; and~* Recombinant epoetin alfa within 8 weeks of study enrollment.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Exercise (Type: EXPERIMENTAL): Study participants were computer randomized to an individualized exercise program. Participants were stratified within Arm according to whether or not they received thalidomide with heparin, and by age (60 and younger versus older than 60)
- usual care (Type: ACTIVE_COMPARATOR): Study participants were asked to remain as active as possible but not prescribed an individualized exercise program. Participants were stratified within Arm according to whether or not they received thalidomide with heparin, and by age (60 and younger versus older than 60)

Based on this trial design, predict the completion outcome and termination type (if applicable).